HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region

American Journal of Human Genetics

Volumn 99, Issue 6, 2016, Pages 1353-1358

  Vince, Nicolas ^a,b   Li, Hongchuan ^a   Ramsuran, Veron ^a,b   Naranbhai, Vivek ^b,c,d   Duh, Fuh Mei ^a   Fairfax, Benjamin P ^c   Saleh, Bahara ^a   Knight, Julian C ^c   Anderson, Stephen K ^a   Carrington, Mary ^a,b  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 1;

ALLELE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL SURFACE; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; ALGORITHM; BIOSYNTHESIS; GENETIC TRANSCRIPTION; GENETICS; HELA CELL LINE; HUMAN GENOME; INFORMATION PROCESSING; METABOLISM;

ALGORITHMS; ALLELES; BINDING SITES; DATASETS AS TOPIC; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HELA CELLS; HLA-C ANTIGENS; HUMANS; OCTAMER TRANSCRIPTION FACTOR-1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; QUANTITATIVE TRAIT LOCI; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 85003864743     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2016.09.023     Document Type: Article

References (40)

1. 1 Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., Parkinson, H., The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42 (2014), D1001–D1006.
2. 2 Robinson, J., Halliwell, J.A., Hayhurst, J.D., Flicek, P., Parham, P., Marsh, S.G., The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res. 43 (2015), D423–D431.
3. 3 Hansen, T.H., Bouvier, M., MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9 (2009), 503–513.
4. 4 Jones, E.Y., Fugger, L., Strominger, J.L., Siebold, C., MHC class II proteins and disease: a structural perspective. Nat. Rev. Immunol. 6 (2006), 271–282.
5. 5 Bashirova, A.A., Martin, M.P., McVicar, D.W., Carrington, M., The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu. Rev. Genomics Hum. Genet. 7 (2006), 277–300.
6. 6 Apps, R., Meng, Z., Del Prete, G.Q., Lifson, J.D., Zhou, M., Carrington, M., Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells. J. Immunol. 194 (2015), 3594–3600.
7. 7 Parham, P., Lomen, C.E., Lawlor, D.A., Ways, J.P., Holmes, N., Coppin, H.L., Salter, R.D., Wan, A.M., Ennis, P.D., Nature of polymorphism in HLA-A, -B, and -C molecules. Proc. Natl. Acad. Sci. USA 85 (1988), 4005–4009.
8. 8 Fellay, J., Shianna, K.V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317 (2007), 944–947.
9. 9 Wellcome Trust Case Control, C., Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007), 661–678.
10. 10 Apps, R., Qi, Y., Carlson, J.M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G.Q., Goulder, P., Brumme, Z.L., et al. Influence of HLA-C expression level on HIV control. Science 340 (2013), 87–91.
11. 11 Kulkarni, S., Savan, R., Qi, Y., Gao, X., Yuki, Y., Bass, S.E., Martin, M.P., Hunt, P., Deeks, S.G., Telenti, A., et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472 (2011), 495–498.
12. 12 Kulkarni, S., Qi, Y., O'hUigin, C., Pereyra, F., Ramsuran, V., McLaren, P., Fellay, J., Nelson, G., Chen, H., Liao, W., et al. Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc. Natl. Acad. Sci. USA 110 (2013), 20705–20710.
13. 13 Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, G.T., McVean, G.A., 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491 (2012), 56–65.
14. 14 Gourraud, P.A., Khankhanian, P., Cereb, N., Yang, S.Y., Feolo, M., Maiers, M., Rioux, J.D., Hauser, S., Oksenberg, J., HLA diversity in the 1000 genomes dataset. PLoS ONE, 9, 2014, e97282.
15. 15 Pruim, R.J., Welch, R.P., Sanna, S., Teslovich, T.M., Chines, P.S., Gliedt, T.P., Boehnke, M., Abecasis, G.R., Willer, C.J., LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26 (2010), 2336–2337.
16. 16 Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J., Sham, P.C., PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81 (2007), 559–575.
17. 17 Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A., Reich, D., Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38 (2006), 904–909.
18. 18 Draper, N.R., Smith, H., Applied Regression Analysis. 1998, Wiley, New York.
19. 19 Fairfax, B.P., Makino, S., Radhakrishnan, J., Plant, K., Leslie, S., Dilthey, A., Ellis, P., Langford, C., Vannberg, F.O., Knight, J.C., Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat. Genet. 44 (2012), 502–510.
20. 20 Grabe, N., AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol. (Gedrukt) 2 (2002), S1–S15.
21. 21 Phillips, K., Luisi, B., The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 302 (2000), 1023–1039.
22. 22 Li, H., Wright, P.W., McCullen, M., Anderson, S.K., Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes. Genes Immun. 17 (2016), 66–74.
23. 23 Ferraris, L., Stewart, A.P., Kang, J., DeSimone, A.M., Gemberling, M., Tantin, D., Fairbrother, W.G., Combinatorial binding of transcription factors in the pluripotency control regions of the genome. Genome Res. 21 (2011), 1055–1064.
24. 24 Sive, H.L., Roeder, R.G., Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes. Proc. Natl. Acad. Sci. USA 83 (1986), 6382–6386.
25. 25 Staudt, L.M., Singh, H., Sen, R., Wirth, T., Sharp, P.A., Baltimore, D., A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 323 (1986), 640–643.
26. 26 Reményi, A., Tomilin, A., Pohl, E., Lins, K., Philippsen, A., Reinbold, R., Schöler, H.R., Wilmanns, M., Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell 8 (2001), 569–580.
27. 27 Kim, M.H., Peterson, D.O., Stimulation of basal transcription from the mouse mammary tumor virus promoter by Oct proteins. J. Virol. 69 (1995), 4717–4726.
28. 28 Pance, A., Oct-1, to go or not to go? That is the PolII question. Biochim. Biophys. Acta 1859 (2016), 820–824.
29. 29 Hwang, S.S., Kim, L.K., Lee, G.R., Flavell, R.A., Role of OCT-1 and partner proteins in T cell differentiation. Biochim. Biophys. Acta 1859 (2016), 825–831.
30. 30 Wang, V.E.H., Schmidt, T., Chen, J., Sharp, P.A., Tantin, D., Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice. Mol. Cell. Biol. 24 (2004), 1022–1032.
31. 31 Vázquez-Arreguín, K., Tantin, D., The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks. Biochim. Biophys. Acta 1859 (2016), 792–804.
32. 32 Curtis, C., Shah, S.P., Chin, S.F., Turashvili, G., Rueda, O.M., Dunning, M.J., Speed, D., Lynch, A.G., Samarajiwa, S., Yuan, Y., et al., METABRIC Group. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486 (2012), 346–352.
33. 33 Hernández, P., Solé, X., Valls, J., Moreno, V., Capellá, G., Urruticoechea, A., Pujana, M.A., Integrative analysis of a cancer somatic mutome. Mol. Cancer, 6, 2007, 13.
34. 34 Jeong, S.H., Lee, Y.J., Cho, B.I., Ha, W.S., Choi, S.K., Jung, E.J., Ju, Y.T., Jeong, C.Y., Ko, G.H., Yoo, J., Hong, S.C., OCT-1 overexpression is associated with poor prognosis in patients with well-differentiated gastric cancer. Tumour Biol. 35 (2014), 5501–5509.
35. 35 Wang, J., Yang, Y.H., Wang, A.Q., Yao, B., Xie, G., Feng, G., Zhang, Y., Cheng, Z.S., Hui, L., Dai, T.Z., et al. Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med. Oncol. 27 (2010), 219–223.
36. 36 Pfeuffer, I., Klein-Hessling, S., Heinfling, A., Chuvpilo, S., Escher, C., Brabletz, T., Hentsch, B., Schwarzenbach, H., Matthias, P., Serfling, E., Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. J. Immunol. 153 (1994), 5572–5585.
37. 37 Ullman, K.S., Flanagan, W.M., Edwards, C.A., Crabtree, G.R., Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 254 (1991), 558–562.
38. 38 Kim, Y.M., Ko, C.B., Park, Y.P., Kim, Y.J., Paik, S.G., Octamer motif is required for the NF-kappaB-mediated induction of the inducible nitric oxide synthase gene expression in RAW 264.7 macrophages. Mol. Cells 9 (1999), 99–109.
39. 39 Ballard, D.W., Bothwell, A., Mutational analysis of the immunoglobulin heavy chain promoter region. Proc. Natl. Acad. Sci. USA 83 (1986), 9626–9630.
40. 40 Xie, Q., A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase. J. Biol. Chem. 272 (1997), 14867–14872.